I last wrote on SpaceX (SPACE) on Mar. 16, 2026. The article rated the stock as a buy after a comparison of its business model against the established United Launch Alliance (ULA). Since then, there ...

One of the commonly stated reasons why companies stay private is the costs (and legal risks) of being public. One of those costs is preparing quarterly SEC reports. But there are also costs of ...

The wheels of the SpaceX IPO were officially put in motion on April 1, with Bloomberg reporting that the company had confidentially filed for an IPO with the Securities and Exchange Commission (SEC).

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. When ...

Forbes contributors publish independent expert analyses and insights. Specialist in global markets, economics and alternative investments. This voice experience is generated by AI. Learn more. This ...

Both Seaport Therapeutics and Hemab Therapeutics are hoping to bring in around $180 million each from their public listings this week, in the latest sign that biotech IPOs are regaining momentum.

Update, April 29 at 2:30 p.m.: Pershing Square opened down 16% in its IPO on Wednesday. PSUS shares were priced at $50 each, and opened around $42 per share. Bill Ackman has made a lot of noise in ...

The U.S. Securities and Exchange Commission (SEC) has a renewed focus on bringing companies to public markets. They quantified some of the benefits to companies of being public in a 2025 staff report, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as ...

Avalyn Pharma is hoping to rake in around $182 million from an IPO, which the biotech will use to take its inhaled versions of approved drugs for respiratory conditions into late-stage studies. The ...